{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:45:41Z","timestamp":1790066741675,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jchromb.2018.12.016","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T17:46:30Z","timestamp":1544809590000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["UHPLC-MS\/MS method for simultaneous determination of carbamazepine and its seven major metabolites in serum of epileptic patients"],"prefix":"10.1016","volume":"1108","author":[{"given":"Wei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlei","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wansheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2018.12.016_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1570-0232(01)00590-6","article-title":"Determination of carbamazepine and carbamazepine 10,11-epoxide in human plasma by tandem liquid chromatography-mass spectrometry with electrospray ionisation","volume":"769","author":"Van Rooyen","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1365\/s10337-009-1456-6","article-title":"Rapid determination of carbamazepine in human urine, plasma samples and water using DLLME followed by RP\u2013LC","volume":"71","author":"Mashayekhi","year":"2010","journal-title":"Chromatographia"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jchromb.2005.09.019","article-title":"Liquid chromatography\u2013electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma","volume":"828","author":"Breton","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0020","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/14656566.2014.879572","article-title":"Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures","volume":"15","author":"Franco","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001031.pub2","article-title":"Lamotrigine versus carbamazepine monotherapy for epilepsy","volume":"6","author":"Gamble","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.seizure.2013.11.016","article-title":"Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsy","volume":"23","author":"Kenyon","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1129-2377-15-34","article-title":"Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain","volume":"15","author":"Stefano","year":"2014","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0040","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.pharep.2014.07.012","article-title":"The influence of amitriptyline and carbamazepine on levomepromazine metabolism in human liver: an in vitro study","volume":"66","author":"W\u00f3jcikowski","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0045","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/MJT.0b013e3182258e51","article-title":"Delayed elevation in carbamazepine concentrations after overdose: a retrospective poison center study","volume":"20","author":"Patel","year":"2013","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0050","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2146\/ajhp080454","article-title":"Carbamazepine-induced hyperammonemia","volume":"66","author":"Adams","year":"2009","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5414\/CPP45121","article-title":"Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients","volume":"45","author":"Babaei","year":"2007","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0378-4347(01)00524-2","article-title":"Separation of carbamazepine and five metabolites, and analysis in human plasma by micellar electrokinetic capillary chromatography","volume":"770","author":"Raggi","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0065","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1124\/dmd.115.063370","article-title":"Carbamazepine-induced liver injury requires CYP3A-mediated metabolism and glutathione depletion in rats","volume":"43","author":"Iida","year":"2015","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.jchromb.2018.12.016_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142408","article-title":"Polymorphic variants of SCN1A and EPHX1 influence plasma carbamazepine concentration, metabolism and pharmacoresistance in a population of Kosovar Albanian epileptic patients","volume":"10","author":"Daci","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1872312811206030008","article-title":"Antiepileptic drugs (AEDs) polypharmacy could lead to buried pharmacokinetic interactions due to CYP450","volume":"6","author":"Toloughamari","year":"2012","journal-title":"Drug Metab. Lett."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1528-1167.2012.03671.x","article-title":"Enzyme induction with antiepileptic drugs: cause for concern?","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0085","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2147\/DDDT.S57409","article-title":"Clinical utility of eslicarbazepine: current evidence","volume":"9","author":"Zaccara","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0090","doi-asserted-by":"crossref","first-page":"651","DOI":"10.4103\/0253-7613.144941","article-title":"Hypoglycemia - a rare complication of carbamazepine overdose","volume":"46","author":"Jha","year":"2014","journal-title":"Indian J. Pharmacol."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0095","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pharep.2014.11.009","article-title":"Antiepileptic drugs and adverse skin reactions: an update","volume":"67","author":"B\u0142aszczyk","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0100","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s12272-014-0375-8","article-title":"Effect of Sophora flavescens on the pharmacokinetics of carbamazepine in rats","volume":"37","author":"Shi","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.pharep.2014.10.002","article-title":"In vivo induction of CYP in mice by carbamazepine is independent on PXR","volume":"67","author":"Liu","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00003088-199120030-00005","article-title":"Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children","volume":"20","author":"Hartley","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0115","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00007691-199009000-00006","article-title":"Factors influencing plasma level\/dose ratios of carbamazepine and its major metabolites in epileptic children","volume":"12","author":"Hartley","year":"1990","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.2042-7158.1973.tb10021.x","article-title":"Iminostilbene\u2014a metabolite of carbamazepine isolated from rat urine","volume":"25","author":"Csetenyi","year":"1973","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0125","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0192-0561(95)00019-X","article-title":"The effect of carbamazepine and its reactive metabolite, 9-acridine carboxaldehyde, on immune cell function in vitro","volume":"17","author":"Furst","year":"1995","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0130","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1248\/bpb.18.926","article-title":"9-Hydroxymethyl-10-carbamoylacridan in human serum is one of the major metabolites of carbamazepine","volume":"18","author":"Eto","year":"1995","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0135","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00007691-199706000-00012","article-title":"Carbamazepine: detection of another metabolite in serum, 9 hydroxymethyl-10-carbamoyl acridan","volume":"19","author":"Wad","year":"1997","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0140","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00007691-199812000-00012","article-title":"Carbamazepine-10,11-epoxide in therapeutic drug monitoring","volume":"20","author":"Potter","year":"1998","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/00498254.2010.529955","article-title":"Presence and ex vivo formation of acridone in blood of patients routinely treated with carbamazepine: exploration of the 9-acridinecarboxaldehyde pathway","volume":"41","author":"Mathieu","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0150","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(00)03137-8","article-title":"Idiosyncratic drug reactions: the reactive metabolite syndromes","volume":"356","author":"Knowles","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0155","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1570-0232(02)00664-5","article-title":"Liquid chromatographic determination of oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction","volume":"783","author":"Mandrioli","year":"2003","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0160","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0378-4347(85)80198-5","article-title":"Determination of antiepileptic drugs","volume":"340","author":"Burke","year":"1985","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/chromsci\/40.4.219","article-title":"Determination of lamotrigine simultaneously with carbamazepine, carbamazepine epoxide, phenytoin, phenobarbital, and primidone in human plasma by SPME-GC-TSD","volume":"40","author":"Queiroz","year":"2002","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0170","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.jhazmat.2010.12.037","article-title":"GC-MS analysis and ecotoxicological risk assessment of triclosan, carbamazepine and parabens in Indian rivers","volume":"186","author":"Ramaswamy","year":"2011","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0175","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jpba.2006.07.047","article-title":"Development and validation of a high performance liquid chromatographic method for the determination of oxcarbazepine and its main metabolites in human plasma and cerebrospinal fluid and its application to pharmacokinetic study","volume":"43","author":"Kimiskidis","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jssc.201100789","article-title":"Novel micro-extraction by packed sorbent procedure for the liquid chromatographic analysis of antiepileptic drugs in human plasma and urine","volume":"35","author":"Rani","year":"2012","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jchromb.2012.01.021","article-title":"Quantification of carbamazepine and its active metabolite by direct injection of human milk serum using liquid chromatography tandem ion trap mass spectrometry","volume":"889\u2013890","author":"Lopes","year":"2012","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2018.12.016_bb0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jat\/bku070","article-title":"Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases","volume":"38","author":"Deeb","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jpba.2004.11.058","article-title":"Liquid chromatography\/tandem mass spectrometry for the determination of carbamazepine and its main metabolite in rat plasma utilizing an automated blood sampling system","volume":"38","author":"Zhu","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2018.12.016_bb0200","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-4347(93)80248-3","article-title":"Simple and accurate high-performance liquid chromatographic method for the measurement of three antiepileptics in therapeutic drug monitoring","volume":"622","author":"Kouno","year":"1993","journal-title":"J. Chromatogr. B"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217315854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023217315854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T08:20:08Z","timestamp":1548577208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023217315854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":40,"alternative-id":["S1570023217315854"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.12.016","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"UHPLC-MS\/MS method for simultaneous determination of carbamazepine and its seven major metabolites in serum of epileptic patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2018.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}